VIETNAM NEWS HEADLINES MARCH 25

First batch of AstraZeneca antibody drug Evusheld arrives in Vietnam Facilities of Tam Anh General Hospital in both Hanoi and Ho Chi Minh City on March 24 received the first batch of Evusheld, a drug developed by AstraZeneca to fight COVID-19 infection by combining two long-acting monoclonal antibodies. The shipment has been made on the basis of a contract for 20,000 doses signed with AstraZeneca by the Vietnam Vaccine Joint Stock Company (VNVC) on November 2, 2021. Evusheld, a long-acting monoclonal antibody, serves as a prevention therapy for people in high-risk groups. It is capable of helping to protect them from COVID-19 infection before they are actually exposed to the virus. It represents the first pre-exposure prophylaxis product created to tackle COVID-19, with the exception of vaccines. In contrast to typical vaccines which are available, Evusheld helps inoculated individuals by producing a necessary amount of antibodies in order to protect them against COVID-19, with an efficiency rate of up to 83%. Those who are unable to be given any of the existing COVID-19 vaccines due to potentially serious side-effects to any of its components such as severe allergy and anaphylaxis can instead choose to get the Evusheld injection. Vietnam wants… Read full this story

VIETNAM NEWS HEADLINES MARCH 25 have 239 words, post on vietnamnet.vn at March 25, 2022. This is cached page on Vietnam Dance. If you want remove this page, please contact us.